Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ON SEMICONDUCTOR CORPON · Entity 3161 | Director · CEO & President | February 20, 2026 | February 24, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ON SEMICONDUCTOR CORP
Report date February 20, 2026 · Filed February 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| CommonSEC Table I · non-derivative | Direct | 1,054,123 |
Ending reported balance
After 2026-02-21 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-02-20 · Grant · Acquired 75,315 · Balance 1,090,925 F1: Represents time-based restricted stock units that will vest in three equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued employment through the applicable vesting date. Row 2 · 2026-02-21 · Tax withholding · Disposed 36,802 · Balance 1,054,123 F2: Represents shares withheld to cover taxes due upon the vesting of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents time-based restricted stock units that will vest in three equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued employment through the applicable vesting date.
F2: Represents shares withheld to cover taxes due upon the vesting of restricted stock units.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CYPRESS SEMICONDUCTOR CORP /DE/
Report date April 16, 2020 · Filed April 17, 2020
Section 16 reporting ended · disclosed 2020-04-17. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-04-16 transaction · row 1
1 source rowRow 1 · 2020-04-16 · Disposition to issuer · Disposed 671,989 · Balance 0 F1: On April 16, 2020 (the "Effective Time"), pursuant to the Agreement and Plan of Merger, dated as of June 3, 2019 (the "Merger Agreement"), by and among Cypress Semiconductor Corporation (the "Issuer"), Infineon Technologies AG ("Infineon") and IFX Merger Sub Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer as the surviving entity and a wholly owned subsidiary of Infineon. Pursuant to the Merger Agreement, each outstanding share of the Issuer's common stock ("Common Stock") was converted into the right to receive $23.85 per share in cash (the "Per Share Merger Consideration"), without interest. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-04-16 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-04-16 · Disposition to issuer · Disposed 32,198 · Balance 0 F2: Restricted stock units convert into common stock on a one-for-one basis upon settlement. F4: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each outstanding restricted stock unit award, whether vested or unvested, was cancelled and converted into the right to receive a cash payment equal to the product of (i) the number of restricted stock units subject to such award immediately prior to the Effective Time multiplied by (ii) the Per Share Merger Consideration. Such payment is to be made at the times and subject to any vesting and acceleration conditions set forth in the Merger Agreement. F3: On February 16, 2018, the Reporting Person was granted 96,594 restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-04-16 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-04-16 · Disposition to issuer · Disposed 73,134 · Balance 0 F2: Restricted stock units convert into common stock on a one-for-one basis upon settlement. F4: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each outstanding restricted stock unit award, whether vested or unvested, was cancelled and converted into the right to receive a cash payment equal to the product of (i) the number of restricted stock units subject to such award immediately prior to the Effective Time multiplied by (ii) the Per Share Merger Consideration. Such payment is to be made at the times and subject to any vesting and acceleration conditions set forth in the Merger Agreement. F5: On February 15, 2019, the Reporting Person was granted 146,268 restricted stock units, with approximately 50% of the units vesting on the first anniversary of the grant date and the remainder of the units vesting in equal installments on the second and third anniversaries of the grant date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-04-16 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2020-04-16 · Disposition to issuer · Disposed 233,867 · Balance 0 F2: Restricted stock units convert into common stock on a one-for-one basis upon settlement. F4: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each outstanding restricted stock unit award, whether vested or unvested, was cancelled and converted into the right to receive a cash payment equal to the product of (i) the number of restricted stock units subject to such award immediately prior to the Effective Time multiplied by (ii) the Per Share Merger Consideration. Such payment is to be made at the times and subject to any vesting and acceleration conditions set forth in the Merger Agreement. F6: On March 1, 2020, the Reporting Person was granted 233,867 restricted stock units that vest in three equal annual installments beginning on February 14, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: On April 16, 2020 (the "Effective Time"), pursuant to the Agreement and Plan of Merger, dated as of June 3, 2019 (the "Merger Agreement"), by and among Cypress Semiconductor Corporation (the "Issuer"), Infineon Technologies AG ("Infineon") and IFX Merger Sub Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer as the surviving entity and a wholly owned subsidiary of Infineon. Pursuant to the Merger Agreement, each outstanding share of the Issuer's common stock ("Common Stock") was converted into the right to receive $23.85 per share in cash (the "Per Share Merger Consideration"), without interest.
F2: Restricted stock units convert into common stock on a one-for-one basis upon settlement.
F3: On February 16, 2018, the Reporting Person was granted 96,594 restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date.
F4: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each outstanding restricted stock unit award, whether vested or unvested, was cancelled and converted into the right to receive a cash payment equal to the product of (i) the number of restricted stock units subject to such award immediately prior to the Effective Time multiplied by (ii) the Per Share Merger Consideration. Such payment is to be made at the times and subject to any vesting and acceleration conditions set forth in the Merger Agreement.
F5: On February 15, 2019, the Reporting Person was granted 146,268 restricted stock units, with approximately 50% of the units vesting on the first anniversary of the grant date and the remainder of the units vesting in equal installments on the second and third anniversaries of the grant date.
F6: On March 1, 2020, the Reporting Person was granted 233,867 restricted stock units that vest in three equal annual installments beginning on February 14, 2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 02, 2017 Filed Aug 3, 2017 17:23 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 927 | $6.70 | $6,207.38 |
DisclosureSEC source: 0001209191-17-047447 · doc4.xml · nonDerivative · entry 1 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,263 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2017 Filed May 12, 2017 16:12 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Tax withholdingCommon Stock | 9,690 | $13.48 | $130,621.20 |
DisclosureSEC source: 0001209191-17-031906 · doc4.xml · nonDerivative · entry 2 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,788 F2 · shares: The sales reported in this Form 4 represent the aggregate number of shares of Issuer common stock sold for payment of the tax liability incident to the vesting of the restricted stock units issued in accordance with Rule 16b-3. F2 · price: The sales reported in this Form 4 represent the aggregate number of shares of Issuer common stock sold for payment of the tax liability incident to the vesting of the restricted stock units issued in accordance with Rule 16b-3. Read SEC document |
| May 10, 2017 Filed May 12, 2017 16:12 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionRestricted Stock Units · Derivative | 18,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-031906 · doc4.xml · derivative · entry 3 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,636 Underlying: Common Stock · 18,404 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. F3 · derivative.exercise_date: On August 10, 2016, the Reporting Person was awarded a grant of 220,848 restricted stock units upon his appointment as President and Chief Executive Officer of the Issuer. This equity grant will vest quarterly in equal installments over the next three years from the date of grant. F3 · derivative.expiration_date: On August 10, 2016, the Reporting Person was awarded a grant of 220,848 restricted stock units upon his appointment as President and Chief Executive Officer of the Issuer. This equity grant will vest quarterly in equal installments over the next three years from the date of grant. Read SEC document |
| May 10, 2017 Filed May 12, 2017 16:12 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 18,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-031906 · doc4.xml · nonDerivative · entry 1 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,478 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Restricted stock units convert into common stock on a one-for-one basis upon vesting. F1 · price: Restricted stock units convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| March 16, 2017 Filed Mar 20, 2017 19:32 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | GrantRestricted Stock Units · Derivative | 158,577 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-021852 · doc4.xml · derivative · entry 1 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,577 Underlying: Common Stock · 158,577 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. F2 · derivative.exercise_date: This equity grant represents a contingent right to receive Issuer common stock on a one-for-one basis. Two-thirds of the RSUs will vest on February 1, 2019 and the remaining one-third will vest on February 3, 2020. F2 · derivative.expiration_date: This equity grant represents a contingent right to receive Issuer common stock on a one-for-one basis. Two-thirds of the RSUs will vest on February 1, 2019 and the remaining one-third will vest on February 3, 2020. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 20:14 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Tax withholdingCommon Stock | 45,775 | $13.31 | $609,045.53 |
DisclosureSEC source: 0001209191-17-017005 · doc4.xml · nonDerivative · entry 3 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 342,074 F4 · price: The price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.3 to $13.33 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 20:14 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 25,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-017005 · doc4.xml · nonDerivative · entry 2 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 387,849 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Represents the aggregate number of shares of Issuer common stock earned upon achieving performance milestones and specific targets pursuant to the April 1, 2016 grant awarded under the Issuer's Stock Plan as part of the Issuer's PARS Program. F2 · price: Each performance-based restricted stock unit represented a contingent right to earn a share of Issuer common stock upon achieving performance milestones and specific targets pursuant to the grant. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 20:14 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 61,920 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-017005 · doc4.xml · nonDerivative · entry 1 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 361,999 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the aggregate number of shares of Issuer common stock earned upon achieving performance milestones and specific targets pursuant to the March 3, 2015 grant awarded under the Issuer's 2013 Stock Plan (the "Stock Plan") as part of the Issuer's Performance Based Accelerated Restricted Stock Program (the "PARS Program"). F2 · price: Each performance-based restricted stock unit represented a contingent right to earn a share of Issuer common stock upon achieving performance milestones and specific targets pursuant to the grant. Read SEC document |
| February 13, 2017 Filed Feb 14, 2017 17:48 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Tax withholdingCommon Stock | 6,876 | $12.44 | $85,523.69 |
DisclosureSEC source: 0001209191-17-010643 · doc4.xml · nonDerivative · entry 2 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,079 Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 17:48 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionRestricted Stock Units · Derivative | 18,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-010643 · doc4.xml · derivative · entry 3 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,040 Underlying: Common Stock · 18,404 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. F2 · derivative.exercise_date: On August 10, 2016, the Reporting Person was awarded a grant of 220,848 RSUs upon his appointment as President and Chief Executive Officer of the Issuer. This equity grant will vest quarterly in equal installments over the next three years from the date of grant. F2 · derivative.expiration_date: On August 10, 2016, the Reporting Person was awarded a grant of 220,848 RSUs upon his appointment as President and Chief Executive Officer of the Issuer. This equity grant will vest quarterly in equal installments over the next three years from the date of grant. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 17:48 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 18,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-010643 · doc4.xml · nonDerivative · entry 1 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,955 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| February 01, 2017 Filed Feb 2, 2017 17:44 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Tax withholdingCommon Stock | 8,470 | $11.76 | $99,585.18 |
DisclosureSEC source: 0001209191-17-007223 · doc4.xml · nonDerivative · entry 2 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,551 Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 17:44 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionRestricted Stock Units · Derivative | 21,494 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007223 · doc4.xml · derivative · entry 3 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,494 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. F2 · derivative.exercise_date: On November 3, 2016, the Reporting Person was granted 21,494 RSUs in lieu of a cash bonus which was payable under existing Issuer incentive programs. This RSU grant represents a contingent right to receive Issuer common stock on a one-for-one basis and was fully vested on January 31, 2017. F2 · derivative.expiration_date: On November 3, 2016, the Reporting Person was granted 21,494 RSUs in lieu of a cash bonus which was payable under existing Issuer incentive programs. This RSU grant represents a contingent right to receive Issuer common stock on a one-for-one basis and was fully vested on January 31, 2017. Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 17:44 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 21,494 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007223 · doc4.xml · nonDerivative · entry 1 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,021 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| January 30, 2017 Filed Jan 31, 2017 18:24 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Tax withholdingCommon Stock | 11,805 | $11.90 | $140,460.61 |
DisclosureSEC source: 0001209191-17-006474 · doc4.xml · nonDerivative · entry 2 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,527 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.74 to $11.935 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 18:24 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionRestricted Stock Units · Derivative | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-006474 · doc4.xml · derivative · entry 3 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. F3 · derivative.exercise_date: On March 3, 2015, the Reporting Person was granted 90,000 service based RSUs, vesting in three equal annual installments beginning on January 29, 2016. F3 · derivative.expiration_date: On March 3, 2015, the Reporting Person was granted 90,000 service based RSUs, vesting in three equal annual installments beginning on January 29, 2016. Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 18:24 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-006474 · doc4.xml · nonDerivative · entry 1 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,332 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| January 10, 2017 Filed Jan 11, 2017 16:34 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Tax withholdingCommon Stock | 357 | $11.45 | $4,087.69 |
DisclosureSEC source: 0001209191-17-003371 · doc4.xml · nonDerivative · entry 2 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,332 Read SEC document |
| January 09, 2017 Filed Jan 11, 2017 16:34 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionRestricted Stock Units · Derivative | 807 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-003371 · doc4.xml · derivative · entry 3 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 807 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. F2 · derivative.exercise_date: Represents a contingent right to receive Issuer common stock on a one-for-one basis. On February 8, 2012, the Reporting Person was granted 4,034 RSUs vesting in five (5) equal annual installments beginning on January 9, 2013. This grant is fully vested. F2 · derivative.expiration_date: Represents a contingent right to receive Issuer common stock on a one-for-one basis. On February 8, 2012, the Reporting Person was granted 4,034 RSUs vesting in five (5) equal annual installments beginning on January 9, 2013. This grant is fully vested. Read SEC document |
| January 09, 2017 Filed Jan 11, 2017 16:34 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 807 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-003371 · doc4.xml · nonDerivative · entry 1 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 20:23 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Tax withholdingCommon Stock | 10,340 | $11.55 | $119,428.03 |
DisclosureSEC source: 0001209191-17-001600 · doc4.xml · nonDerivative · entry 2 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,956 Read SEC document |
| December 31, 2016 Filed Jan 4, 2017 20:23 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionRestricted Stock Units · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-001600 · doc4.xml · derivative · entry 3 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: On May 5, 2016, the Reporting Person was granted 20,000 RSUs in connection with his appointment by the Issuer's board of directors (the "board") as a member of the Office of the President and Chief Executive Officer (the "OCEO"). The OCEO was formed by the Issuer's board to perform the duties of the Issuer's president and chief executive officer until such time as a successor to the Issuer's president and chief executive officer was duly appointed and reported directly to the Issuer's board. The grant was scheduled to vest in full on December 31, 2016 upon the Reporting Person's continued service to the Issuer through that date. F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. F2 · derivative.exercise_date: On May 5, 2016, the Reporting Person was granted 20,000 RSUs in connection with his appointment by the Issuer's board of directors (the "board") as a member of the Office of the President and Chief Executive Officer (the "OCEO"). The OCEO was formed by the Issuer's board to perform the duties of the Issuer's president and chief executive officer until such time as a successor to the Issuer's president and chief executive officer was duly appointed and reported directly to the Issuer's board. The grant was scheduled to vest in full on December 31, 2016 upon the Reporting Person's continued service to the Issuer through that date. F2 · derivative.expiration_date: On May 5, 2016, the Reporting Person was granted 20,000 RSUs in connection with his appointment by the Issuer's board of directors (the "board") as a member of the Office of the President and Chief Executive Officer (the "OCEO"). The OCEO was formed by the Issuer's board to perform the duties of the Issuer's president and chief executive officer until such time as a successor to the Issuer's president and chief executive officer was duly appointed and reported directly to the Issuer's board. The grant was scheduled to vest in full on December 31, 2016 upon the Reporting Person's continued service to the Issuer through that date. Read SEC document |
| December 31, 2016 Filed Jan 4, 2017 20:23 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 20,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-001600 · doc4.xml · nonDerivative · entry 1 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,296 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| November 15, 2016 Filed Nov 16, 2016 18:08 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Tax withholdingCommon Stock | 249 | $10.71 | $2,667.11 |
DisclosureSEC source: 0001209191-16-150670 · doc4.xml · nonDerivative · entry 2 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,296 Read SEC document |
| November 14, 2016 Filed Nov 16, 2016 18:08 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionRestricted Stock Units · Derivative | 467 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-150670 · doc4.xml · derivative · entry 3 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 467 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. F2 · derivative.exercise_date: On December 1, 2011, the Reporting Person was awarded a grant of 2,333 RSUs. This equity grant vested annually beginning November 14, 2012 and is fully vested. F2 · derivative.expiration_date: On December 1, 2011, the Reporting Person was awarded a grant of 2,333 RSUs. This equity grant vested annually beginning November 14, 2012 and is fully vested. Read SEC document |
| November 14, 2016 Filed Nov 16, 2016 18:08 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 467 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-16-150670 · doc4.xml · nonDerivative · entry 1 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,545 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| November 10, 2016 Filed Nov 15, 2016 17:01 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionRestricted Stock Units · Derivative | 18,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-150217 · doc4.xml · derivative · entry 3 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,444 Underlying: Common Stock · 18,404 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. F2 · derivative.exercise_date: On August 10, 2016, the Reporting Person was awarded a grant of 220,848 RSUs upon his appointment as President and Chief Executive Officer of the Issuer. This equity grant will vest quarterly in equal installments over the next three (3) years from the date of grant. F2 · derivative.expiration_date: On August 10, 2016, the Reporting Person was awarded a grant of 220,848 RSUs upon his appointment as President and Chief Executive Officer of the Issuer. This equity grant will vest quarterly in equal installments over the next three (3) years from the date of grant. Read SEC document |
| November 10, 2016 Filed Nov 15, 2016 17:01 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Tax withholdingCommon Stock | 9,745 | $10.45 | $101,840.12 |
DisclosureSEC source: 0001209191-16-150217 · doc4.xml · nonDerivative · entry 2 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,078 Read SEC document |
| November 10, 2016 Filed Nov 15, 2016 17:01 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | Exercise / conversionCommon Stock | 18,404 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-16-150217 · doc4.xml · nonDerivative · entry 1 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,823 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| November 03, 2016 Filed Nov 7, 2016 18:48 UTC | CYPRESS SEMICONDUCTOR CORP /DE/ CY · Entity 149819 | GrantRestricted Stock Units · Derivative | 21,494 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-148727 · doc4.xml · derivative · entry 1 El-Khoury Hassane · CIK 0001558882 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,494 Underlying: Common Stock · 21,494 shares Expires not disclosed F1 · security: The Reporting Person was awarded an equity grant of Restricted Stock Units ("RSUs") in lieu of a cash bonus which was payable under existing Issuer incentive programs. The RSU grant represents a contingent right to receive Issuer common stock on a one-for-one basis and is fully vested on January 31, 2017. F2 · derivative.exercise_price: This equity grant represents a contingent right to receive Issuer common stock on a one-for-one basis upon vesting of the RSUs. F2 · price: This equity grant represents a contingent right to receive Issuer common stock on a one-for-one basis upon vesting of the RSUs. F3 · derivative.exercise_date: This equity grant represents a contingent right to receive Issuer common stock on a one-for-one basis and is fully vested on January 31, 2017. F3 · derivative.expiration_date: This equity grant represents a contingent right to receive Issuer common stock on a one-for-one basis and is fully vested on January 31, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.